ArticleHealth science reports2026
The Association Between Number of Chronic Conditions and Benzodiazepine Prescribing in Region Stockholm, Sweden: A Total Population-Based Cohort Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: The aim of this study was to examine the association between an increasing number of chronic conditions and prescribing of benzodiazepines. Methods: Conditional logistic regression was used to study the association between the number of chronic conditions accumulated during a 4-year period and risk of having ≥ 2 collected prescriptions of benzodiazepines during the 2 following years in two cohorts before and during the COVID-19 pandemic. Data were collected from the VAL databases for the total adult population in Stockholm, Sweden between January 1, 2014 and December 31, 2019, and January 1, 2016 and December 31, 2021. Results: Of the total population with approximately 1.3 million individuals in each cohort, 3.8% of the women and 2.2% of the men had ≥ 2 collected prescriptions of benzodiazepines before the COVID-19 pandemic. During the COVID-19 pandemic, 3.1% of the women and 1.8% of the men had ≥ 2 collected prescriptions of benzodiazepines. The risk of having ≥ 2 collected prescriptions of benzodiazepines significantly increased in individuals with two chronic conditions, compared to the reference group, OR 3.25 (3.25-3.25) for women, and OR 3.57 (CI 3.57-3.58) for men before COVID-19. The risk increased with an increasing number of chronic conditions, OR 11.41 (CI 11.40-11.42) for women and OR 13.26 (CI 13.25-13.28) for men with 5-9 conditions before COVID-19. Results were similar during the COVID-19 pandemic. The association regarded both ongoing and new prescriptions. Conclusion: In this study, individuals with an increasing number of chronic conditions were more likely to receive both ongoing and newly initiated benzodiazepine prescriptions. While the appropriateness of prescribing was not assessed in this study, these findings can inform healthcare providers and policymakers about the need for strategies to reduce such prescribing in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.